ArticleJournal of immunology research2026
T Follicular Helper Cell Immune Signatures Associated With Disease Severity in Severe Fever With Thrombocytopenia Syndrome.
Article in Journal of immunology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- T Follicular Helper Cell Immune Signatures Associated With Disease Severity in Severe Fever With Thrombocytopenia Syndrome.Journal of immunology research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundSevere fever with thrombocytopenia syndrome (SFTS) is marked by high case fatality and profound antiviral immune dysregulation, yet the clinical implications of changes in circulating T follicular helper (Tfh) cells remain unclear.
methodsWe enrolled 79 patients with RT-PCR-confirmed SFTSV infection who were hospitalized from May to October 2023 and categorized them as acute-phase survivors (AS) or acute-phase deceased (AD). Frequencies of circulating Tfh subsets (Tfh1, Tfh2, Tfh17, and PD-1
resultsCompared with survivors, patients in the AD group showed greater inflammatory activation, more pronounced coagulation disturbances, and higher plasma viral loads. While overall circulating Tfh frequencies were elevated in AD patients, subset profiling demonstrated a clear bias toward Tfh2 expansion together with contraction of Tfh1 and Tfh17 populations. Among these subsets, Tfh2 had the best discriminatory value for mortality (AUC = 0.724). Lower Tfh1 and Tfh17 frequencies were associated with poorer 28-day survival. Viral RNA levels were positively related to total Tfh and Tfh2 frequencies and negatively related to Tfh17. After adjustment for age, HLH status, and viral load, Tfh1 remained an independent correlate of acute-phase mortality.
conclusionsAcute SFTSV infection is associated with substantial remodeling of the circulating Tfh compartment. Expansion of Tfh2 alongside reduction of Tfh1 and Tfh17 was linked to heavier viral burden and worse clinical outcome. The independent association between lower Tfh1 frequency and mortality suggests that Tfh profiling may be useful for early risk assessment and offers mechanistic insight into defective humoral immunity in severe SFTS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.